Emla cream-induced allergic contact dermatitis in a child with thalassaemia major.
Ismail
F
F
Department of Dermatology, Royal London Hospital, London, UK. f.ismail@qmul.ac.uk
Goldsmith
P C
PC
D000005:Abdomen; D000485:Allergens / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000009:adverse effects*; D002648:Child; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D003937:Diagnosis, Differential; D006801:Humans; D007279:Injections, Subcutaneous; D007502:Iron Chelating Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008012:Lidocaine / Q000009:adverse effects*; D000077442:Lidocaine, Prilocaine Drug Combination; D008297:Male; D010328:Patch Tests; D011318:Prilocaine / Q000009:adverse effects*; D017086:beta-Thalassemia / Q000188:drug therapy
D000485:Allergens; D000779:Anesthetics, Local; D007502:Iron Chelating Agents; D000077442:Lidocaine, Prilocaine Drug Combination; D011318:Prilocaine; D008012:Lidocaine; D003676:Deferoxamine